Solon Eiendom ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solon Eiendom ASA with three other
pharmaceutical manufacturers in Europe:
Quantum Pharma PLC
of the United Kingdom
sales of £69.99 million [US$93.20 million]
of which 85%
(705.90 million Swedish Kronor [US$87.17 million]
of which 68%
was Zubsolv), and
based in Romania
(332.44 million Romanian Leu [US$86.06 million]
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Solon Eiendom ASA were NOK 691.50 million (US$87.90 million).
increase of 813,425.9%
versus 2015, when the company's sales were NOK 85,000.00 .